These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 9122730

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma.
    Kruper LL, Spitz FR, Czerniecki BJ, Fraker DL, Blackwood-Chirchir A, Ming ME, Elder DE, Elenitsas R, Guerry D, Gimotty PA.
    Cancer; 2006 Nov 15; 107(10):2436-45. PubMed ID: 17058288
    [Abstract] [Full Text] [Related]

  • 5. Predicting ten-year survival of patients with primary cutaneous melanoma: corroboration of a prognostic model.
    Sahin S, Rao B, Kopf AW, Lee E, Rigel DS, Nossa R, Rahman IJ, Wortzel H, Marghoob AA, Bart RS.
    Cancer; 1997 Oct 15; 80(8):1426-31. PubMed ID: 9338466
    [Abstract] [Full Text] [Related]

  • 6. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
    Taylor RC, Patel A, Panageas KS, Busam KJ, Brady MS.
    J Clin Oncol; 2007 Mar 01; 25(7):869-75. PubMed ID: 17327608
    [Abstract] [Full Text] [Related]

  • 7. Classification of localized melanoma by the exponential survival trees method.
    Huang X, Soong S, McCarthy WH, Urist MM, Balch CM.
    Cancer; 1997 Mar 15; 79(6):1122-8. PubMed ID: 9070489
    [Abstract] [Full Text] [Related]

  • 8. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
    Mandalà M, Imberti GL, Piazzalunga D, Belfiglio M, Labianca R, Barberis M, Marchesi L, Poletti P, Bonomi L, Novellino L, Di Biagio K, Milesi A, Guerra U, Tondini C.
    Eur J Cancer; 2009 Sep 15; 45(14):2537-45. PubMed ID: 19553103
    [Abstract] [Full Text] [Related]

  • 9. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center.
    Azzola MF, Shaw HM, Thompson JF, Soong SJ, Scolyer RA, Watson GF, Colman MH, Zhang Y.
    Cancer; 2003 Mar 15; 97(6):1488-98. PubMed ID: 12627514
    [Abstract] [Full Text] [Related]

  • 10. Age and gender are significant independent predictors of survival in primary cutaneous melanoma.
    Lasithiotakis K, Leiter U, Meier F, Eigentler T, Metzler G, Moehrle M, Breuninger H, Garbe C.
    Cancer; 2008 Apr 15; 112(8):1795-804. PubMed ID: 18306371
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors.
    Massi D, Borgognoni L, Franchi A, Martini L, Reali UM, Santucci M.
    Melanoma Res; 2000 Apr 15; 10(2):153-64. PubMed ID: 10803716
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
    Schmidt H, Suciu S, Punt CJ, Gore M, Kruit W, Patel P, Lienard D, von der Maase H, Eggermont AM, Keilholz U, American Joint Committee on Cancer Stage IV Melanoma, EORTC 18951.
    J Clin Oncol; 2007 Apr 20; 25(12):1562-9. PubMed ID: 17443000
    [Abstract] [Full Text] [Related]

  • 16. Risk assessment in localized primary cutaneous melanoma: a Southwest Oncology Group study evaluating nine factors and a test of the Clark logistic regression prediction model.
    Tuthill RJ, Unger JM, Liu PY, Flaherty LE, Sondak VK, Southwest Oncology Group.
    Am J Clin Pathol; 2002 Oct 20; 118(4):504-11. PubMed ID: 12375635
    [Abstract] [Full Text] [Related]

  • 17. The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up.
    Francken AB, Shaw HM, Thompson JF, Soong SJ, Accortt NA, Azzola MF, Scolyer RA, Milton GW, McCarthy WH, Colman MH, McGovern VJ.
    Ann Surg Oncol; 2004 Apr 20; 11(4):426-33. PubMed ID: 15070604
    [Abstract] [Full Text] [Related]

  • 18. Prognostic factors in patients with thick cutaneous melanoma (> 4 mm).
    Zettersten E, Sagebiel RW, Miller JR, Tallapureddy S, Leong SP, Kashani-Sabet M.
    Cancer; 2002 Feb 15; 94(4):1049-56. PubMed ID: 11920475
    [Abstract] [Full Text] [Related]

  • 19. [The factors of disease-free survival in patients with nodal metastases of cutaneous melanoma].
    Mikhnin AE, Barchuk AS.
    Vopr Onkol; 2004 Feb 15; 50(4):426-9. PubMed ID: 15605765
    [Abstract] [Full Text] [Related]

  • 20. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
    Cherpelis BS, Haddad F, Messina J, Cantor AB, Fitzmorris K, Reintgen DS, Fenske NA, Glass LF.
    J Am Acad Dermatol; 2001 May 15; 44(5):762-6. PubMed ID: 11312421
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.